Table 2.
Summary of laboratory data of study subjects with and without metabolic syndrome.
| Metabolic Syndrome | Non-Metabolic Syndrome | ||||
|---|---|---|---|---|---|
| Mean ± SD | Range | Mean ± SD | Range | p-Value | |
| N | 151 | 1661 | |||
| RBC (104/μL) | 479.6 ± 40.8 | 378, 598 | 453.8 ± 42.6 | 272, 631 | <0.0001 ** |
| WBC (/μL) | 5797.2 ± 1394.2 | 2880, 11,310 | 4934.4 ± 1239.8 | 2280, 13,210 | <0.0001 ** |
| Hb (g/dL) | 14.9 ± 1.2 | 11.5, 17.5 | 13.9 ± 1.4 | 5.3, 18.4 | <0.0001 ** |
| Hct (%) | 43.8 ± 3.3 | 35.0, 51.8 | 41.5 ± 3.7 | 20.4, 53.9 | <0.0001 ** |
| AST (IU/L) | 27.4 ± 14.9 | 13, 146 | 21.3 ± 11.0 | 7, 388 | <0.0001 ** |
| ALT (IU/L) | 34.7 ± 26.2 | 10, 191 | 19.7 ± 12.4 | 6, 232 | <0.0001 ** |
| γ-GTP (IU/L) | 50.8 ± 48.7 | 8, 345 | 28.1 ± 29.0 | 6, 450 | <0.0001 ** |
| ALP (IU/L) | 220.2 ± 58.7 | 109, 444 | 204.4 ± 58.2 | 65, 638 | 0.0015 ** |
| LDH (IU/L) | 188.7 ± 33.0 | 126, 349 | 179.5 ± 37.0 | 69, 1069 | 0.0032 * |
| ChE (IU/L) | 373.2 ± 60.0 | 230, 549 | 333.2 ± 71.7 | 134, 1029 | <0.0001 ** |
| ZTT (KU) | 7.6 ± 3.3 | 1, 16 | 8.0 ± 3.4 | 1, 28 | 0.2040 |
| Bil (mg/dL) | 0.99 ± 0.4 | 0.4, 3.4 | 0.93 ± 0.34 | 0.3, 3.5 | 0.0235 * |
| TP (g/dL) | 7.3 ± 0.4 | 6.4, 8.6 | 7.2 ± 0.4 | 6.0, 8.7 | 0.0009 ** |
| Albumin (g/dL) | 4.3 ± 0.2 | 3.7, 5.0 | 4.3 ± 0.2 | 3.2, 5.3 | 0.2289 |
| BUN (mg/dL) | 15.8 ± 4.3 | 8, 30 | 14.6 ± 3.6 | 6, 33 | <0.0001 ** |
| Cre (mg/dL) | 0.9 ± 0.3 | 0.52, 2.34 | 0.7 ± 0.2 | 0.33, 1.48 | <0.0001 ** |
| eGFR (mL/min/1.73 m3) | 65.8 ± 14.3 | 24.2, 98.7 | 73.8 ± 13.6 | 30.9, 145.5 | <0.0001 ** |
| UA (mg/dL) | 6.0 ± 1.3 | 3.0, 9.3 | 5.2 ± 1.2 | 0.5, 9.3 | <0.0001 ** |
| T-Chol (mg/dL) | 206.3 ± 37.0 | 116, 324 | 214.6 ± 33.2 | 87, 327 | 0.0034 ** |
| Fasting TG (mg/dL) | 162.2 ± 146.3 | 43, 1670 | 91.9 ± 58.9 | 19, 1037 | <0.0001 ** |
| HDL (mg/dL) | 57.3 ± 13.1 | 29, 107 | 73.1 ± 18.9 | 30, 158 | <0.0001 ** |
| LDL (mg/dL) | 124.2 ± 30.7 | 43, 225 | 127.0 ± 29.3 | 35, 239 | 0.2559 |
| non-HDL (mg/dL) | 149.0 ± 36.5 | 78, 259 | 141.6 ± 32.1 | 38, 267 | 0.0074 ** |
| Fasting BG (mg/dL) | 112.4 ± 20.3 | 81, 217 | 94.3 ± 11.7 | 57, 184 | <0.0001 ** |
| HbA1c (%) | 6.2 ± 0.7 | 5.1, 8.2 | 8.7 ± 0.4 | 4.7, 8.7 | <0.0001 ** |
| Amylase (IU/L) | 83.6 ± 33.6 | 30, 218 | 85.0 ± 28.3 | 28, 318 | 0.6365 |
| Lipase (IU/L) | 32.5 ± 11.5 | 8, 85 | 34.0 ± 12.2 | 8.0, 249.0 | 0.1376 |
| CRP (mg/dL) | 0.16 ± 0.20 | 0.01, 1.27 | 0.10 ± 0.51 | 0.0, 17.4 | 0.1701 |
Comparison between metabolic syndrome and non-metabolic syndrome groups by using unpaired student’s t test for continuous data. The * and ** correspond to the significance levels at 5% (p < 0.05) and 1% (p < 0.01), respectively. N, number of participants; SD, standard deviation; IU, international unit; RBC, red blood cell; WBC white blood count; Hb, hemoglobin; Hct, hematocrit; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; ChE, cholinesterase; ZTT, zinc sulfate turbidity test; KU, kunkel unit; Bil, total bilirubin; TP, total protein; BUN, blood urea nitrogen; Cre, creatinine; eGFR, estimated glomerular filtration rate; UA, uric acid; T-Chol, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; non-HDL, non-high-density lipoprotein; BG, blood glucose; HbA1c, hemoglobin A1c; CRP, C-reactive protein.